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Abstract
Background: Little is known at the molecular level concerning the differences and/or similarities
between alcohol and hepatitis C virus induced liver disease. Global transcriptional profiling using
oligonucleotide microarrays was therefore performed on liver biopsies from patients with cirrhosis
caused by either chronic alcohol consumption or chronic hepatitis C virus (HCV).
Results: Global gene expression patterns varied significantly depending upon etiology of liver
disease, with a greater number of differentially regulated genes seen in HCV-infected patients. Many
of the gene expression changes specifically observed in HCV-infected cirrhotic livers were
expectedly associated with activation of the innate antiviral immune response. We also compared
severity (CTP class) of cirrhosis for each etiology and identified gene expression patterns that
differentiated ethanol-induced cirrhosis by class. CTP class A ethanol-cirrhotic livers showed
unique expression patterns for genes implicated in the inflammatory response, including those
related to macrophage activation and migration, as well as lipid metabolism and oxidative stress
genes.
Conclusion: Stages of liver cirrhosis could be differentiated based on gene expression patterns in
ethanol-induced, but not HCV-induced, disease. In addition to genes specifically regulating the
innate antiviral immune response, mechanisms responsible for differentiating chronic liver damage
due to HCV or ethanol may be closely related to regulation of lipid metabolism and to effects of
macrophage activation on deposition of extracellular matrix components.
Background
More than 170 million people worldwide are chronically
infected with hepatitis C virus (HCV) [1] and about 20%
of those infected will develop cirrhosis [2]. The incidence
of cirrhosis development due to chronic alcohol exposure
is similar, and half the causes of death following end-stage
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liver disease are due to this etiology [3,4]. In alcoholic
liver disease (ALD), the metabolism of ethanol plays a
role in pathogenesis [5-8], and there is increasing evi-
dence for specific roles played by the immune response
[4][5,9-15]. Ethanol can suppress innate immunity in
mice by attenuating the TLR3-ds RNA signaling pathway
and subsequent interferon (IFN) response [11], as well as
in actively drinking patients by decreasing expression of
CD28/B7 co-stimulatory pathways [10]. In addition, β-
chemokine production and migration of mononuclear
cells has been observed during later stages of ALD [13].
Early cirrhosis due to HCV infection can be difficult to rec-
ognize, as there are often only nonspecific symptoms
associated with its progression. The standard method of
determining the severity of disease and appropriate treat-
ment has been the liver biopsy [16], but histological
examination of the biopsy gives limited information on
what is occurring at the molecular level. Therefore, identi-
fying gene expression patterns in liver tissue during cirrho-
sis development could add valuable information to
clinical tests. Functional genomics is increasingly being
utilized to investigate the mechanisms underlying the
development of liver disease. During chronic HCV infec-
tion in humans, broad activation of the endogenous type
I IFN pathway has been observed by genomic analysis
[17]. Microarray analysis of liver biopsies from HCV-
infected patients has also revealed genes associated with
activated lymphocytes, extracellular matrix, and macro-
phages, that could be possible markers for fibrosis pro-
gression[18,19]. In mice, expression of the HCV core
protein results in down regulation in the expression of
lipid metabolism-associated genes [20]. Other virus-host
interactions, including SARS-CoV [21], influenza virus
[22], and Ebola [23], have also been successfully studied
by functional genomics. Gene expression profiling using
microarray technology clearly makes it possible to obtain
global transcriptional changes associated with a diseased
state caused by many factors, which could help identify
pathways implicated in progression of disease [24].
In the current report we utilized functional genomic anal-
ysis to compare gene expression patterns in cirrhotic liv-
ers, including various Child-Turcotte-Pugh (CTP)-
classifications, associated with either chronic alcohol con-
sumption or HCV infection. The pathology of alcohol-
and HCV-induced cirrhosis is very similar and characteris-
tic fibrosis patterns leading to cirrhosis can overlap among
these two etiologies [25]. Therefore, it is particularly use-
ful to now have the tools for genomic analysis, in order to
determine how cirrhosis development may differ between
these two distinct etiologies. Upon analysis, we indeed
found differences in the expression of interferon-related
genes and lymphocyte-specific genes between alcoholic
and viral etiologies. Interestingly, a clear distinction
existed between CTP classes of ALD, but not HCV-associ-
ated, cirrhosis. Different expression patterns depending
on severity of alcohol-induced cirrhosis were found in
genes associated with the inflammatory response, lipid
metabolism, and oxidative stress. This information could
be integral in increasing understanding of underlying
mechanisms at work during end-stage liver disease.
Results
Global gene expression patterns distinguish ethanol- and 
HCV-induced cirrhosis
To analyze gene expression changes in cirrhotic livers
associated with HCV (n = 8) or ethanol (n = 7), microar-
ray experiments were performed comparing each type of
cirrhotic liver to a reference pool of normal liver tissue.
Cirrhosis severity was evaluated according to the CTP clin-
ical scoring system (A-C, least to most severe, respectively)
and patient scores are summarized in Table 1. The global
gene expression profiles of all experiments are shown in
Figure 1. In total, 2,965 genes were differentially
expressed (≥ 2-fold, P ≤ 0.05) in at least 3 of 15 samples.
The clustering algorithm demonstrates that global gene
expression profiles clearly distinguish ethanol- and HCV-
associated cirrhotic samples (indicated with black and
blue text, respectively). Substantially more gene expres-
sion changes were observed in HCV-related samples com-
pared to ethanol-related, ranging from 574–1622 in HCV
samples as compared to 79–683 in ethanol samples.
Interestingly, the gene expression patterns observed were
relatively uniform among HCV-cirrhotic samples and did
not appear to differ between CTP classes. In contrast, the
global gene expression profiles demonstrated distinct pat-
terns among CTP classes in ethanol-related cirrhosis.
Gene expression changes specific to HCV-infected 
cirrhotic livers are associated with induction of the innate 
antiviral immune response
To further classify functional pathways specifically associ-
ated with etiology, we performed a one-way error-
weighted ANOVA comparison of HCV- and ethanol-asso-
ciated cirrhotic liver biopsies. A set of 946 genes was iden-
tified as being significantly (P ≤ 0.05) different with
respect to expression level between the two groups. We
then used Fatigo software to analyze functional groups
that differed between cirrhosis etiologies. Genes associ-
ated with metabolism, the immune response, and cell
death were differentially regulated in HCV- and alcohol-
related cirrhosis. Many of the genes specifically induced in
HCV-associated cirrhotic livers were not up-regulated in
ethanol-cirrhotic livers. This appears to be at least partly
related to activation of the innate antiviral immune
response, as many of these up-regulated genes are known
to be regulated by IFN (Fig. 2A). Specifically, a subset of
genes highly induced in HCV-associated cirrhotic samples
were IFNα/β-inducible (IRF7, OAS2, GIP2, GIP3) or takeVirology Journal 2006, 3:98 http://www.virologyj.com/content/3/1/98
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part in its activation. Additional IFN-type I genes – OAS1,
IFITM1, IFI35, IFIT1, MX1, IFI27 – were highly up-regu-
lated in HCV-associated samples but not included in this
ANOVA. A small set of genes (ISG20, IFI16, TRIM22,
STAT5A) were also highly up-regulated in nearly all sam-
ples, including ethanol-cirrhotic livers, suggesting these
may play a role in an inflammatory response related to cir-
rhosis development regardless of etiology.
Significant infiltration of lymphocytes into the liver is
observed during chronic HCV infection [26]. In this study,
up-regulation of gene markers for lymphocytes was
indeed much more pronounced in HCV-infected liver
samples than in ethanol-induced livers (Fig. 2B, Addi-
tional file 1). Specifically, RANTES, which is chemotactic
for T cells in vitro was significantly up-regulated in all
HCV-infected livers (1.8–4.5 fold, P ≥ 0.05). In contrast,
circulating levels of natural killer cells have been shown to
be suppressed under the influence of alcohol [27,28].
Consistent with this, we observed decreased expression of
natural killer cell-related genes, including CD44, IL15R,
CD2 and CCL5, in alcohol-associated cirrhotic liver sam-
ples.
Gene expression patterns differentiate ethanol-associated 
cirrhosis by CTP class
Whereas HCV-associated cirrhotic samples looked very
similar regardless of CTP class (Fig. 1), global gene expres-
sion profiles indicated that CTP class A ethanol-associated
samples exhibited unique expression patterns from CTP
class B and C samples. In order to further identify which
gene expression patterns were specific depending on
severity of ethanol-associated cirrhosis, we performed a
one-way error-weighted ANOVA (P ≤ 0.05) of less severe
(CTP class A) cirrhotic samples versus more severe (CTP
classes B and C) samples (Fig. 3A, Additional file 2).
Expression profiles distinguished the ethanol-related CTP
class A samples from ethanol-related CTP class B and C
samples. In general, class A samples demonstrated up-reg-
ulation of more genes than in samples with more severe
cirrhosis (Class B and C). Distinct gene expression profiles
were not observed between CTP classes B and C, but this
may be due to small sample size. Ingenuity analysis of
groups I and II (Fig. 3A) demonstrated that the number of
genes associated with various biological functions dif-
fered significantly depending on severity of alcohol cir-
rhosis. Of 135 annotated genes up-regulated in group II,
60 were associated with cell death as compared to only 16
in group I. High numbers of genes related to cell move-
ment, mainly of phagocytes, and tissue development were
also up-regulated in more severe ethanol cirrhosis. Many
genes in group I (less severe cirrhosis) were associated
with lipid metabolism, specifically the metabolism of
cholesterol. Genes involved in the function of the
immune and lymphatic system, such as activation of
mononuclear leukocytes and proliferation of macro-
phages, were also up-regulated in early, less severe cirrho-
sis.
A number of genes that were nearly exclusively up-regu-
lated in the CTP-A class of ethanol cirrhosis included
inflammatory-related genes (Fig. 3B). Some of these –
VIPR1, CCL15, PLG, CCR3, CSF1 – are involved in macro-
phage activation and migration. Macrophage-related
genes not in this ANOVA set but also highly up-regulated
in CTP class A samples included FN1, C5, LPA, and
SERPINA3.
Interestingly, severe ethanol cirrhosis differed from less
severe ethanol cirrhosis in expression of genes associated
with fatty and bile acid metabolism (Fig. 3C). Many of
these genes were up-regulated during less severe cirrhosis
but down-regulated by end-stage ethanol cirrhosis. Sterol
27-hydroxylase (CYP27A1) oxidizes cholesterol in the
Table 1: Patient profile
Patient # Sex Age Etiology Child-Pugh Length of alcohol consumption Quantity of alcohol consumed ALT/AST
1239 M 68 Alcohol A several years > 100 g/day 28/37
1240 M 70 Alcohol A several years > 100 g/day 36/44
1245 M 67 Alcohol A unknown unknown 19/19
1263 M 72 Alcohol A > 20 years 80 g/day 82/89
1164 M 62 Alcohol B > 30 years > 80 g/day 33/27
1227 M 59 Alcohol C 39 years active at OLT > 100 g/day 28/54
1228 M 44 Alcohol C 18 years > 100 g/day 18/27
1015 M 47 HCV A N/A none 96/45
1019 M 66 HCV A N/A none 77/99
1022 M 61 HCV A N/A none 113/143
1023 M 67 HCV A N/A none 90/115
1037 F 54 HCV B N/A none 57/78
1038 M 55 HCV B N/A none 69/108
1035 M 59 HCV C N/A none 87/100
1039 M 66 HCV C N/A none 90/35Virology Journal 2006, 3:98 http://www.virologyj.com/content/3/1/98
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alternative pathway of bile acid biosynthesis; a defect in
this enzyme leads to excessive accumulation of sterols
[29]. We observed significant up-regulation of this gene in
livers of all patients with early ethanol cirrhosis and, as
with other genes in this group, down-regulation during
late (end-stage) cirrhosis (Figure 3C). Fatty acids are sub-
strates for cytochrome CYP2E1 (P450 2E1) [5], which is a
key enzyme in the microsomal ethanol oxidation system
and plays a role in alcohol detoxification and nutritional
support [30]. It is also a major source of oxidative stress
[6,5], and both protein and mRNA levels increase dramat-
ically in actively drinking patients [31]. Therefore it was
interesting that significant down-regulation of this gene
was also observed in high grade (CTP class B and C) cir-
rhotic livers (Figure 3C). A similar pattern was observed
for genes encoding alcohol dehydrogenases (ADH4,
ADH1B, ADH1C).
Differences in global gene expression profiles between HCV  and ethanol-associated cirrhotic liver tissue Figure 2
Differences in global gene expression profiles 
between HCV and ethanol-associated cirrhotic liver 
tissue. A. Expression of genes associated with IFN response. 
HCV- and EtOH-associated cirrhosis samples were clustered 
based on the expression of IFN-related genes that were at 
least 2-fold regulated with a P value ≤ 0.05 in at least 3 of 15 
experiments, comparing cirrhotic tissue to a normal liver ref-
erence. See legend of Fig. 1 for details on clustering, the 
applied color scheme for the fold changes in the mRNA lev-
els, and experiment representation. B. Expression of genes 
associated with lymphocyte activation and proliferation. Cir-
rhotic samples were again clustered based on the expression 
of lymphocyte-related genes that were at least 2-fold regu-
lated with a P value ≤ 0.05 in at least 3 of 15 experiments 
comparing cirrhotic tissue to a normal liver reference. See 
legend of Fig. 1 for details on clustering, the applied color 
scheme for the fold changes in the mRNA levels, and experi-
ment representation. See Supplementary Table 1 for a list of 
gene names represented in Figure 2B.
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Global gene expression analysis of liver tissue from HCV and  ethanol-associated cirrhosis Figure 1
Global gene expression analysis of liver tissue from 
HCV and ethanol-associated cirrhosis. 2-D hierarchical 
clustering was performed using Resolver System software 
with agglomerative algorithm, average link heuristic criteria, 
and Euclidian correlation metric. Each column represents 
gene expression data from an individual experiment compar-
ing cirrhotic and normal liver and the cluster represents 
2965 genes that showed a >2-fold change (P value < 0.05) in 
at least 3 of 15 experiments. A full view is shown with green 
and red colors showing decreased or increased levels, 
respectively, of mRNA expression relative to normal (non-
cirrhotic, uninfected) tissue. HCV-infected samples are high-
lighted in blue.
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Differences in global gene expression profiles between different CTP classes of ethanol-associated cirrhotic liver tissue Figure 3
Differences in global gene expression profiles between different CTP classes of ethanol-associated cirrhotic 
liver tissue. A. Expression profiles of genes differentially expressed in ethanol-related cirrhosis CTP class A versus CTP BC 
(identified from one-way ANOVA). Each column represents gene expression data from an individual experiment comparing 
cirrhotic and normal liver and the cluster represents genes that showed a >2-fold change (P value < 0.05) in at least 3 of 7 
experiments. See legend of Fig. 1 for details on clustering, the applied color scheme for the fold changes in the mRNA levels, 
and experiment representation. Grouping (I and II) is discussed in the text and demonstrates differences between CTP classes 
in gene expression associated with various biological processes. Refer to Supplementary Table 2 for gene names in each group. 
B. Expression of genes associated with the inflammatory response. Cluster depicts expression of genes that were at least 2-
fold regulated with a P value ≤ 0.05 in at least 3 of 7 experiments comparing cirrhotic tissue to a normal liver reference. See 
legend of Fig. 1 for details on clustering, the applied color scheme for the fold changes in the mRNA levels, and experiment 
representation C. Expression of genes involved in fatty acid and bile acid metabolism. Expression of genes that were at least 2-
fold regulated with a P value ≤ 0.05 in at least 3 of 15 experiments comparing cirrhotic tissue to a normal liver reference. See 
legend of Fig. 1 for details on clustering, the applied color scheme for the fold changes in the mRNA levels, and experiment 
representation.
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Differential gene expression in ethanol-induced class A 
cirrhosis
CTP class A alcohol-associated samples appeared to have
unique expression profiles compared to all other samples
regardless of etiology (Fig. 1). We therefore performed a
one-way error-weighted ANOVA (P ≥ 0.05) of less severe
(CTP class A alcohol-associated) versus more severe etha-
nol-related and HCV-associated cirrhotic samples to iden-
tify genes with expression levels unique to CTP class A
alcohol. Of 607 total genes in this set, a cluster of 273
were highly up-regulated in all samples but ethanol CTP
class A (Fig. 4, group I), and a cluster of 109 were highly
up-regulated specifically in class A (Fig. 4, group II); see
Additional file 3 for more information on gene names.
Functional analysis (Ingenuity) revealed that genes associ-
ated with cell death, movement, and the immune
response were much more abundant in group I than in
group II. Most immune response genes up-regulated in
group I were generally involved in proliferation and
migration of leukocytes, while those in group II were
again related to activation and infiltration of macro-
phages. The majority of genes up-regulated in group II of
early ethanol cirrhosis are involved in the modification of
lipids. The response to oxidative stress was also signifi-
cantly different in early ethanol cirrhosis as related to all
other samples. Two genes in particular were highly up-reg-
ulated in CTP class A livers – PRDX2 (up to 4.7 fold) and
APOE (up to 17.5 fold) – and either less up-regulated or
even down-regulated in the majority of the remaining
samples.
Discussion
Global gene expression profiling of liver biopsy material
revealed significant differences between HCV and etha-
nol-induced cirrhosis. In general, gene expression changes
in cirrhotic livers are more numerous in HCV-infected liv-
ers compared to alcohol-induced diseased livers. Gene
expression patterns can also distinguish classes of etha-
nol-associated cirrhosis. Additionally, unique differences
in gene expression existed between early ethanol cirrhosis
and all other liver samples.
The majority of these differences between HCV and etha-
nol etiologies involved the expression of genes associated
with the immune response, including the IFN response
and infiltration of immune cells. This suggests that the
immune response may play a more prominent role in
viral versus ethanol-induced cirrhosis. Our data showing
significant up-regulation of IFN-type I genes specifically in
HCV-associated samples are also consistent with previous
studies that demonstrated activation of innate antiviral
signaling pathways during HCV infections in chimps [32]
and humans [17,18,26,33-37].
In this report, gene markers for lymphocytes were also
very pronounced in HCV-infected livers. Increased expres-
sion of RANTES – chemotactic for T cells – has been
observed in livers of chronically-infected HCV patients
[38] and a correlation has been found between increased
expression of RANTES in the liver and the extent of liver
damage [39]. That we observed significant up-regulation
of genes related to lymphocyte infiltration exclusively in
HCV-infected cirrhotic livers may have some significance
for how liver injury differs in HCV- and ethanol-cirrhosis.
It has already been shown that liver injury during chronic
HCV infection is associated with increased expression of
TH1 cytokines [40,41]. However, T-cell activation is also
Differences in global gene expression profiles between etha- nol-induced (Class A) cirrhotic tissue versus HCV (Class A,  B, C) and ethanol (Class B and C)-induced cirrhotic tissue Figure 4
Differences in global gene expression profiles 
between ethanol-induced (Class A) cirrhotic tissue 
versus HCV (Class A, B, C) and ethanol (Class B and 
C)-induced cirrhotic tissue. Expression profiles of genes 
differentially expressed in early ethanol-related cirrhosis ver-
sus all other samples; as identified by ANOVA. Each column 
represents gene expression data from an individual experi-
ment comparing cirrhotic and normal liver and the cluster 
represents genes that showed a >2-fold change (P value < 
0.05) in at least 3 of 15 experiments. See legend of Fig. 1 for 
details on clustering and the applied color scheme. Refer to 
Supplementary Table 3 for names of genes represented in 
this figure.
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seen in patients during chronic alcohol consumption
[42]. The present study points to a predominant role of
the immune response in liver pathogenesis well into the
latest stages of HCV-associated disease, and T cells seem to
be important in this response. Though the activation of T
cells appears to contribute to liver injury in chronic ALD,
our observations suggest that the immune response could
be more important in the stages before cirrhosis develops,
but no longer predominant during cirrhosis progression.
Significant differences in gene expression patterns
between classes of ethanol-associated liver cirrhosis point
to the role of macrophages in progression of ethanol-
induced liver disease. Macrophages and other cells of the
innate immune system have already been implicated in
liver injury during alcoholic liver disease [43-47,12-14].
Induction of cytokine production by Kupffer cells acti-
vates hepatic stellate cells, leading to excess accumulation
of extracellular matrix and fibrosis development. Produc-
tion of cytokines and reactive oxygen species from mono-
cytes has been shown to increase in response to chronic
alcohol intake but decrease with acute alcohol intake [43].
We found an increase in the expression of macrophage-
related genes in early less severe (CTP A) ethanol cirrhosis,
but not in late more severe (CTP B and C) ethanol cirrho-
sis. Though sample number does not allow for strictly
defining less or more severe cirrhotics, the trend observed
may have some significance related to regulation of
metabolism.
Genes specifically linked to metabolism also demon-
strated differential regulation depending on cirrhosis
stage in alcoholic liver disease. The metabolism of alcohol
leads to fat accumulation and oxidative stress which,
through the activation of hepatic stellate cells, eventually
leads to liver fibrosis [48]. As the CYP system is the most
important enzyme system for drug metabolism, it is inter-
esting that several genes encoding these proteins were up-
regulated only in livers exhibiting early ethanol cirrhosis.
CYP27A1, an oxidizer of cholesterol, and CYP2E1, a key
enzyme in the microsomal ethanol oxidation system,
were both up-regulated in most early (CTP class A) cirrho-
sis samples but significantly down-regulated by more
severe, end-stage cirrhosis. As CYP27A1 is an acute phase
gene repressed by lipopolysaccharide and cytokines, it is
possible that the down-regulation of this gene is linked to
levels of cytokine activity during late-stage ethanol cirrho-
sis [49].
We know that Kupffer cells harbor CYP2E1 [50], become
active in ALD, and produce inflammatory cytokines [4]. It
could therefore be consistent that we observe both an
increase in expression of macrophage-related genes as
well as genes involved in cholesterol oxidation at the same
(early) stages of cirrhosis. Macrophages may be an impor-
tant source for lipid metabolism enzyme activity at the
beginning stages of cirrhosis, but become less necessary as
there is decreased demand for active metabolism of alco-
hol. Again, this is only speculation as we realize that sam-
ple size is limiting our ability to definitively group CTP
class B with CTP class C as late/severe cirrhotics. Alterna-
tively, this down-regulation of genes during later stages of
ethanol cirrhosis may reflect widespread cell death and
shut-down of liver function.
It is interesting that there were no significant changes in
gene expression patterns observed between classes of
HCV-induced cirrhotic livers. This may be evidence for a
uniform host response throughout cirrhosis development
in this etiology. However, it is more likely that the similar-
ities seen among HCV-infected livers are due to the antivi-
ral host response to HCV infection.
Conclusion
It is clear that gene expression profiles in ethanol-induced
and HCV-induced liver cirrhosis are distinct. We have
identified functional groups that differ both between eti-
ologies and within ethanol-induced cirrhosis, depending
on the extent of liver damage. The data suggest that oxida-
tive stress, lipid metabolism, and macrophage activity
may be more associated with severe liver injury leading to
cirrhosis in ALD than in viral-induced disease. In contrast,
the adaptive immune response, characterized by T cell-
mediated killing of HCV-infected cells, appears to be
more associated with the development of liver cirrhosis in
viral-, but not alcohol-mediated disease. The study sup-
ports the idea that though these different etiologies lead to
similar pathologies, the cellular mechanisms responsible
for disease progression may be unique. Although we real-
ize the limitations of a small cross-sectional study, the
gene expression patterns identified here are from a large
set of genes in order to give a broad global perspective.
These initial findings will contribute to further studies to
distinguish which pathways can differentiate develop-
ment of liver damage due to etiology, which could lead to
better-targeted therapies for end-stage liver disease.
Methods
Human Liver Tissue Samples
Cirrhotic liver samples from 7 alcoholic and 8 HCV-
infected patients were obtained from liver disease patients
at the University of Barcelona, Spain who underwent liver
transplant or hepatic resection. None of the HCV-infected
patients in this study were undergoing anti-viral treatment
at the time the liver sample was obtained. Alcohol con-
sumption information was based on data obtained in
patient interviews. The severity of cirrhosis was clinically
graded according to Child-Turcotte-Pugh (CTP) scores
(summarized in Table 1). Normal, uninfected liver tissue
from 8 patients who underwent tumor resection due toVirology Journal 2006, 3:98 http://www.virologyj.com/content/3/1/98
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metastases of non-liver origin was collected at the same
clinic (non-tumor material was used). These uninfected
samples were pooled to create a standard normal liver ref-
erence (pNL) that was used for all microarray experi-
ments. All patients gave informed prior consent to
protocols approved by the University of Barcelona, Spain.
Total RNA Isolation and mRNA Amplification
Frozen liver tissues were disrupted in Trizol Reagent (Inv-
itrogen, Carlsbad, CA) using a Polytron homogenizer
(PowerGene 700, Fisher Scientific), and total RNA was
isolated according to the Trizol protocol. All total RNA
samples were double amplified using the RiboAmp RNA
Amplification kit (Arcturus, Mountain View, CA). The
quality of amplified RNA was evaluated by capillary elec-
trophoresis using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA).
Expression Microarray Format and Data Analysis
Microarray format, protocols for probe labeling, hybridi-
zation, slide treatment, and scanning were performed as
previously described [35] and are also available at our
website [51]. Human cDNA set 1 expression arrays carry-
ing 13,026 unique cDNA clones were purchased from Agi-
lent. A single experiment comparing two samples, one
from a liver with infection and one from the normal liver
reference, was performed with four replicate arrays using
the dye label reverse technique as described before, thus
providing mean ratios between the expression levels of
each gene in the analyzed sample pair, standard devia-
tions, and P values [35,52-54]. All data were entered into
a custom-designed database, Expression Array Manager,
and then uploaded into Rosetta Resolver System 4.0
(Rosetta Biosoftware, Kirkland, WA) and Spotfire Deci-
sion Suite 7.1.1 (Spotfire, Somerville, MA). Data normal-
ization and the Resolver System Error model specifically
developed for this array format are described on the web
site [51]. This web site is also used to publish all primary
data in accordance with the proposed standards [55]. The
annotation sites Fatigo [56] and Ingenuity [57] were used
to classify genes into functional groups.
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